4AB
AbbVie, Inc. · XETR:4AB
258.30 EUR0.8000 +0.31%
AbbVie, Inc. (XETR:4AB) last traded at 258.30 EUR, up 0.31% on the day. Over the past year the stock is up 36.52%. Its 52-week range is 162.85 to 270.70. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open257.90
Day range256.00 – 258.30
52-week range162.85 – 270.70
Volume166
Average volume (10 days)615
Market cap (USD)510.41 B
P/E50.30
EPS (TTM) (USD)5.82
Dividend yield2.40%
Beta (1 year)0.0129
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+0.31%1 week
+11.48%1 month
+22.01%3 months
+47.39%6 months
+32.19%Year to date
+36.52%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Most and least shorted mid- to mega-cap healthcare stocks at the end of OctoberSeeking Alpha · 03 Nov 2026
- AbbVie Is Maintained at Neutral by UBSDow Jones Newswires · 02 Nov 2026
- AbbVie Is Maintained at Outperform by Leerink PartnersDow Jones Newswires · 02 Nov 2026
- AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestMarketBeat · 02 Nov 2026
- AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology TransitionGuruFocus · 02 Nov 2026
- AbbVie Price Target Raised to $346.00/Share From $310.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
- Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.